Eli Lilly and Company

Eli Lilly and Company, founded in 1876 by Colonel Eli Lilly, is a global leader in the pharmaceutical industry, headquartered in Indianapolis, Indiana. The company specializes in the discovery, development, and manufacturing of innovative medicines across various therapeutic areas, including diabetes, oncology, immunology, and neuroscience. Lilly's portfolio includes notable products such as Mounjaro (tirzepatide) for type 2 diabetes and Zepbound for obesity, both of which have significantly contributed to the company's growth. In 2025, Eli Lilly became the first pharmaceutical company to achieve a market capitalization exceeding $1 trillion, underscoring its strong market position. The company operates in approximately 125 countries, with offices in 18 countries, reflecting its extensive global presence. Eli Lilly's mission is to make medicines that help people live longer, healthier, and more active lives, emphasizing a commitment to innovation, patient-centricity, and social responsibility. Under the leadership of David A. Ricks, Eli Lilly has achieved record research and development output and innovative medicines, positioning the company for sustained growth.